The CDC reports the U.S. infant mortality rate dropped to an all-time low of 5.4 per 1,000 live births in 2025, saving hundreds of lives compared to prior years. Yet the nation remains behind other wealthy countries, highlighting persistent gaps in maternal-child health equity and the need for targeted policy and technology-driven interventions.
About Respiratory Syncytial Virus coverage
This page surfaces every story mentioning Respiratory Syncytial Virus across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
What you see
What it tells you
Story count
Number of distinct stories where Respiratory Syncytial Virus was a primary or referenced actor.
Recency clustering
Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distribution
Aggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche links
When the same entity surfaces in our sibling networks, we link to those views to enrich context.